Literature DB >> 25009448

Treating interstitial cystitis/bladder pain syndrome as a chronic disease.

Philip C Bosch1, David C Bosch2.   

Abstract

The management of interstitial cystitis/bladder pain syndrome (IC/BPS) is both frustrating and difficult. The etiology is uncertain and there is no definitive treatment. Consequently, both patients and doctors tend to be unhappy and unsatisfied with the quality of care. The American Urological Association (AUA) provides a guideline for the diagnosis and treatment of IC/BPS. Recommended first-line treatments include patient education, self-care practices, behavior modifications, and stress management. Management of IC/BPS may be also improved if both patients and doctors treat this condition as a chronic disease. This article reviews the AUA first-line treatments for IC/BPS and considers the benefits of treating this condition as a chronic disease.

Entities:  

Keywords:  Autoimmune diseases; Bladder pain syndrome; Chronic disease; Interstitial cystitis

Year:  2014        PMID: 25009448      PMCID: PMC4080853     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  31 in total

1.  The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis.

Authors:  R A Bologna; A Gomelsky; J C Lukban; L M Tu; A S Holzberg; K E Whitmore
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

2.  Treatment of interstitial cystitis with a quercetin supplement.

Authors:  F Katske; D A Shoskes; M Sender; R Poliakin; K Gagliano; J Rajfer
Journal:  Tech Urol       Date:  2001-03

3.  Stress and symptoms in patients with interstitial cystitis: a life stress model.

Authors:  N E Rothrock; S K Lutgendorf; K J Kreder; T Ratliff; B Zimmerman
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

4.  Interstitial cystitis: successful management by increasing urinary voiding intervals.

Authors:  C L Parsons; P F Koprowski
Journal:  Urology       Date:  1991-03       Impact factor: 2.649

5.  Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.

Authors:  E Rovner; K J Propert; C Brensinger; A J Wein; M Foy; A Kirkemo; J R Landis; J W Kusek; L M Nyberg
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

Review 6.  Coping with chronic pain: a critical review of the literature.

Authors:  Mark P Jensen; Judith A Turner; Joan M Romano; Paul Karoly
Journal:  Pain       Date:  1991-12       Impact factor: 6.961

7.  Psychosocial phenotyping in women with interstitial cystitis/painful bladder syndrome: a case control study.

Authors:  J Curtis Nickel; Dean A Tripp; Michel Pontari; Robert Moldwin; Robert Mayer; Lesley K Carr; Raggi Doggweiler; Claire C Yang; Nagendra Mishra; Jorgen Nordling
Journal:  J Urol       Date:  2010-01       Impact factor: 7.450

8.  Assessing self-help issues for patients with prostate cancer, interstitial cystitis, erectile dysfunction and urinary diversion.

Authors:  R H Breau; P J McGrath; R W Norman
Journal:  BJU Int       Date:  2003-11       Impact factor: 5.588

9.  Behavioral therapy for the treatment of refractory interstitial cystitis.

Authors:  D C Chaiken; J G Blaivas; S T Blaivas
Journal:  J Urol       Date:  1993-06       Impact factor: 7.450

10.  Questions persist: environmental factors in autoimmune disease.

Authors:  Charles W Schmidt
Journal:  Environ Health Perspect       Date:  2011-06       Impact factor: 9.031

View more
  12 in total

1.  Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: A case-control study.

Authors:  Amit Agrawal; Susanta Tripathy; Deepak Kumar
Journal:  Indian J Urol       Date:  2020-07-01

Review 2.  Sexual Dysfunction in Interstitial Cystitis.

Authors:  Senol Tonyali; Mehmet Yilmaz
Journal:  Curr Urol       Date:  2017-11-30

Review 3.  Imaging brain mechanisms in chronic visceral pain.

Authors:  Emeran A Mayer; Arpana Gupta; Lisa A Kilpatrick; Jui-Yang Hong
Journal:  Pain       Date:  2015-04       Impact factor: 7.926

Review 4.  Mast Cell-Mediated Mechanisms of Nociception.

Authors:  Anupam Aich; Lawrence B Afrin; Kalpna Gupta
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

Review 5.  Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2018-06-26       Impact factor: 4.546

Review 6.  An Overview of the Pathology and Emerging Treatment Approaches for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Asad Ali; Nouman Safdar Ali; Muhammad Bilal Malik; Zohaib Sayyed; Malik Qistas Ahmad
Journal:  Cureus       Date:  2018-09-17

7.  Qualitative Analysis of Treatment Needs in Interstitial Cystitis/Bladder Pain Syndrome: Implications for Intervention.

Authors:  Lindsey C McKernan; Kemberlee R Bonnet; Michael T M Finn; David A Williams; Stephen Bruehl; W Stuart Reynolds; Daniel Clauw; Roger R Dmochowski; David G Schlundt; Leslie J Crofford
Journal:  Can J Pain       Date:  2020-09-01

8.  How do women with interstitial cystitis/bladder pain syndrome make treatment choices?

Authors:  Uduak Andy; Lily Arya; Daisy Hassani; Lorraine Flick; Hareena Sangha; Lily A Brown
Journal:  Int Urogynecol J       Date:  2021-10-02       Impact factor: 2.894

9.  Elevated level of nerve growth factor in the bladder pain syndrome/interstitial cystitis: a meta-analysis.

Authors:  Wei Chen; Da-Yong Ye; Deng-Jun Han; Guang-Qing Fu; Xiang Zeng; Wei Lin; Yong Liang
Journal:  Springerplus       Date:  2016-07-13

Review 10.  Intravesical liposome drug delivery and IC/BPS.

Authors:  Joseph J Janicki; Michele A Gruber; Michael B Chancellor
Journal:  Transl Androl Urol       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.